MX9705061A - Hidroximetilimidazodiazepinas y sus esteres. - Google Patents

Hidroximetilimidazodiazepinas y sus esteres.

Info

Publication number
MX9705061A
MX9705061A MX9705061A MX9705061A MX9705061A MX 9705061 A MX9705061 A MX 9705061A MX 9705061 A MX9705061 A MX 9705061A MX 9705061 A MX9705061 A MX 9705061A MX 9705061 A MX9705061 A MX 9705061A
Authority
MX
Mexico
Prior art keywords
hydrogen
hydroxymethylimidazodiazepines
esters
halogen
formula
Prior art date
Application number
MX9705061A
Other languages
English (en)
Other versions
MXPA97005061A (es
Inventor
Rene Borer
Bernd Buttelmann
Max Gerecke
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9705061A publication Critical patent/MX9705061A/es
Publication of MXPA97005061A publication Critical patent/MXPA97005061A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion está relacionada con hidroximetil-imidazodiazepinas y sus ésteres de formula general I. Estos compuestos pueden usarse como sustancias activas ansiolíticas y/o anticonvulsantes y/o relajantes musculares y/o sedativas-hipnoticas.
MXPA/A/1997/005061A 1995-01-06 1997-07-04 Hidroximetilimidazodiazepinas y sus esteres MXPA97005061A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH28/95-9 1995-01-06
CH2895 1995-01-06
PCT/CH1996/000001 WO1996020941A1 (de) 1995-01-06 1996-01-03 Hydroxymethyl-imidazodiazepine und deren ester

Publications (2)

Publication Number Publication Date
MX9705061A true MX9705061A (es) 1997-10-31
MXPA97005061A MXPA97005061A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
DK0801651T3 (da) 2001-10-22
DE59607274D1 (de) 2001-08-16
BR9606823A (pt) 1997-12-30
JP3001979B2 (ja) 2000-01-24
GR3036867T3 (en) 2002-01-31
CA2209424A1 (en) 1996-07-11
PT801651E (pt) 2001-12-28
AU4296196A (en) 1996-07-24
ATE203026T1 (de) 2001-07-15
WO1996020941A1 (de) 1996-07-11
US6174881B1 (en) 2001-01-16
CN1168140A (zh) 1997-12-17
FI972865A0 (fi) 1997-07-04
JPH10500998A (ja) 1998-01-27
EP0801651A1 (de) 1997-10-22
ES2159714T3 (es) 2001-10-16
FI972865A (fi) 1997-09-03
EP0801651B1 (de) 2001-07-11
TR199700587T1 (xx) 1998-02-21

Similar Documents

Publication Publication Date Title
FI834137A0 (fi) Bensodiazepinreceptoraktiva foereningar och foerfarande foer deras framstaellning
ES2159714T3 (es) Hidroximetil-imidazodiazepinas y sus esteres.
TW370450B (en) Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
MX9205242A (es) Compuestos heterociclicos que contienen nitrogeno triciclico fusionado.
FI970150A0 (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
MY115960A (en) Method of administering crf antagonists
ES8604128A1 (es) Un procedimiento para la preparacion de nuevos derivados de bencenosulfonamida
HK1009273A1 (en) Sertindole prodrugs
ATE234818T1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
HK1018782A1 (en) 2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments
YU46068B (sh) 2,3,4,5,6,7-heksahidro-2,7-metano-1,5-benzoksa zoninske oz.-1,4-benzoksazoninske spojine, postopek za njihovo pripravo in njihova uporaba
MX9703288A (es) Oxazolil- y tiazolilimidazo-benzo- y tienodiacepinas y su uso como medicamentos.
ES2010089A6 (es) Procedimiento para la obtencion de n-oxidos de gamma-carbolina antipsicoticos.
CO5040091A1 (es) Derivados de urea
BG101554A (en) 14l, 17l-c2-bonded 19-nor-progesteron derivatives
FI964278A0 (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdannaisten valmistamiseksi
ZA942970B (en) Pyrido(1,2,3-de)quinoxaline derivatives, process for their production and their use in pharmaceutical agents.
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
MX9203518A (es) 9-amino-2-fenilbiciclo [3.3.1] nonanos y 9-amino-2-fenilbiciclo [3.3.1] non-2-enos y drogas que los contienen.
ES8106307A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepi-nas
MX9800925A (es) Uso de derivados de adamantano para tratar enfermedades del oido interno.
GB2013656A (en) 3-alkoxycarbonyl- benzodiazepines
MX9704000A (es) Tintes de benzopirano y sus productos intermedios.